{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:23:53Z","timestamp":1791624233680,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"DOI":"10.7759\/cureus.66850","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T12:49:55Z","timestamp":1723639795000},"source":"Crossref","is-referenced-by-count":2,"title":["Non-ischemia Cardiomyopathy and Polycythemia Secondary to Anabolic-Androgenic Steroid Use"],"prefix":"10.7759","author":[{"given":"Raquel","family":"Rudy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Basree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasems","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.7983","article-title":"Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases","volume":"86","author":"Basaria S","year":"2001","unstructured":"Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001, 86:5108-17. 10.1210\/jcem.86.11.7983","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope HG Jr","year":"2014","unstructured":"Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014, 35:341-75. 10.1210\/er.2013-1058","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0557","article-title":"Anabolic androgenic steroid abuse in young males","volume":"9","author":"de Ronde W","year":"2020","unstructured":"de Ronde W, Smit DL. Anabolic androgenic steroid abuse in young males. Endocr Connect. 2020, 9:R102-11. 10.1530\/EC-19-0557","journal-title":"Endocr Connect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.26773\/smj.181020","article-title":"Anabolic steroid use in sports and in physical activity: overview and analysis","volume":"16","author":"Mazzeo F","year":"2018","unstructured":"Mazzeo F. Anabolic steroid use in sports and in physical activity: overview and analysis. Sport Mont. 2018, 16:113-8. 10.26773\/smj.181020","journal-title":"Sport Mont"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9010097","article-title":"Adverse effects of anabolic-androgenic steroids: a literature review","volume":"9","author":"Albano GD","year":"2021","unstructured":"Albano GD, Amico F, Cocimano G, et al.. Adverse effects of anabolic-androgenic steroids: a literature review. Healthcare (Basel). 2021, 9:97. 10.3390\/healthcare9010097","journal-title":"Healthcare (Basel)"},{"key":"ref6","unstructured":"Diagnostic approach to the patient with erythrocytosis\/polycythemia. (2023). Accessed. 08\/05\/2024: https:\/\/www.uptodate.com\/contents\/diagnostic-approach-to-the-patient-with-erythrocytosis-polycythemia?search=polycyth...."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203033","article-title":"Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient","volume":"2014","author":"Shamloul RM","year":"2014","unstructured":"Shamloul RM, Aborayah AF, Hashad A, Abd-Allah F. Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2013-203033","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081313","article-title":"Severe cardiac and metabolic pathology induced by steroid abuse in a young individual","volume":"11","author":"Tirla A","year":"2021","unstructured":"Tirla A, Vesa CM, Cavalu S. Severe cardiac and metabolic pathology induced by steroid abuse in a young individual. Diagnostics (Basel). 2021, 11:1313. 10.3390\/diagnostics11081313","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2018.06.008","article-title":"Anabolic androgenic steroid use as a cause of fulminant heart failure","volume":"34","author":"White M","year":"2018","unstructured":"White M, Brennan E, Mi Ren KY, Shi M, Thakrar A. Anabolic androgenic steroid use as a cause of fulminant heart failure. Can J Cardiol. 2018, 34:1369.e1-3. 10.1016\/j.cjca.2018.06.008","journal-title":"Can J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe D","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014, 24:383-98. 10.1016\/j.annepidem.2014.01.009","journal-title":"Ann Epidemiol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1989.03420080085036","article-title":"Contrasting effects of testosterone and stanozolol on serum lipoprotein levels","volume":"261","author":"Thompson PD","year":"1989","unstructured":"Thompson PD, Cullinane EM, Sady SP, Chenevert C, Saritelli AL, Sady MA, Herbert PN. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA. 1989, 261:1165-8.","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1670639","article-title":"Anabolic androgenic steroid abuse: the effects on thrombosis risk, coagulation, and fibrinolysis","volume":"44","author":"Chang S","year":"2018","unstructured":"Chang S, M\u00fcnster AB, Gram J, Sidelmann JJ. Anabolic androgenic steroid abuse: the effects on thrombosis risk, coagulation, and fibrinolysis. Semin Thromb Hemost. 2018, 44:734-46. 10.1055\/s-0038-1670639","journal-title":"Semin Thromb Hemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a014724","article-title":"Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters","volume":"17","author":"Nieminen MS","year":"1996","unstructured":"Nieminen MS, R\u00e4m\u00f6 MP, Viitasalo M, Heikkil\u00e4 P, Karjalainen J, M\u00e4ntysaari M, Heikkil\u00e4 J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J. 1996, 17:1576-83. 10.1093\/oxfordjournals.eurheartj.a014724","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s4261","article-title":"Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature","volume":"4","author":"Stergiopoulos K","year":"2008","unstructured":"Stergiopoulos K, Brennan JJ, Mathews R, Setaro JF, Kort S. Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. Vasc Health Risk Manag. 2008, 4:1475-80. 10.2147\/vhrm.s4261","journal-title":"Vasc Health Risk Manag"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06112","article-title":"Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma","volume":"186","author":"T'Sjoen GG","year":"2005","unstructured":"T'Sjoen GG, Beguin Y, Feyen E, Rubens R, Kaufman JM, Gooren L. Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. J Endocrinol. 2005, 186:61-7. 10.1677\/joe.1.06112","journal-title":"J Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-149-38767","article-title":"Increase in erythroid colony formation in rabbits following the administration of testosterone","volume":"149","author":"Moriyama Y","year":"1975","unstructured":"Moriyama Y, Fisher JW. Increase in erythroid colony formation in rabbits following the administration of testosterone. Proc Soc Exp Biol Med. 1975, 149:178-80. 10.3181\/00379727-149-38767","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199906)61:2%3C154::AID-AJH17%3E3.0.CO;2-S","article-title":"Androgen-induced erythrocytosis: is it erythropoietin?","volume":"61","author":"Dickerman RD","year":"1999","unstructured":"Dickerman RD, Pertusi R, Miller J, Zachariah NY. Androgen-induced erythrocytosis: is it erythropoietin?. Am J Hematol. 1999, 61:153-8. 10.1002\/(SICI)1096-8652(199906)61:2%3C154::AID-AJH17%3E3.0.CO;2-S","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223891","article-title":"Cardiomyopathy induced by anabolic-androgenic steroid abuse","volume":"2018","author":"Garner O","year":"2018","unstructured":"Garner O, Iardino A, Ramirez A, Yakoby M. Cardiomyopathy induced by anabolic-androgenic steroid abuse. BMJ Case Rep. 2018, 2018:bcr-2017-223891. 10.1136\/bcr-2017-223891","journal-title":"BMJ Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-229004","article-title":"Gerstmann syndrome complicating polycythemia secondary to anabolic steroid use","volume":"12","author":"Long N","year":"2019","unstructured":"Long N, Bassi S, Pepito D, Akhondi H. Gerstmann syndrome complicating polycythemia secondary to anabolic steroid use. BMJ Case Rep. 2019, 12:e229004. 10.1136\/bcr-2018-229004","journal-title":"BMJ Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110587","article-title":"Sudden cardiac death in anabolic-androgenic steroid users: a literature review","volume":"56","author":"Torrisi M","year":"2020","unstructured":"Torrisi M, Pennisi G, Russo I, et al.. Sudden cardiac death in anabolic-androgenic steroid users: a literature review. Medicina (Kaunas). 2020, 56:587. 10.3390\/medicina56110587","journal-title":"Medicina (Kaunas)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5455\/msm.2018.30.49-52","article-title":"Prevalence, attitude, knowledge, and practice of anabolic androgenic steroid (AAS) use among gym participants","volume":"30","author":"Althobiti SD","year":"2018","unstructured":"Althobiti SD, Alqurashi NM, Alotaibi AS, Alharthi TF, Alswat KA. Prevalence, attitude, knowledge, and practice of anabolic androgenic steroid (AAS) use among gym participants. Mater Sociomed. 2018, 30:49-52. 10.5455\/msm.2018.30.49-52","journal-title":"Mater Sociomed"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.17226\/5153","article-title":"Schools and health: our nation's investment","year":"1997","unstructured":"Schools and health. our nation's investment. Allensworth D, Lawson E, Nicholson L, Wyche J (ed): National Academies Press, Washington (DC); 1997. 10.17226\/5153"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017, 136:e137-61. 10.1161\/CIR.0000000000000509","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136508-non-ischemia-cardiomyopathy-and-polycythemia-secondary-to-anabolic-androgenic-steroid-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T12:50:02Z","timestamp":1723639802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136508-non-ischemia-cardiomyopathy-and-polycythemia-secondary-to-anabolic-androgenic-steroid-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.66850","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}